What's new

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised

Apr 1, 2025 - 14:49
 0
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Marks’ exit is not exactly helping industry sentiment

Next Article

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, D...

Related Posts

Withdrawn application: Dupixent, 18/02/2025

Withdrawn application: Dupixent, 18/02/2025

Feb 28, 2025  0

EMEA-003071-PIP02-23

EMEA-003071-PIP02-23

Feb 13, 2025  0

EMEA-003472-PIP01-23

EMEA-003472-PIP01-23

Feb 17, 2025  0